[Role of hyperglycemia in the development of diabetic microangiopathy].
Miyata
Satoshi
S
Department of Internal Medicine, Kobe Kaisei Hospital.
Kasuga
Masato
M
D000818:Animals; D017209:Apoptosis; D003847:Deoxyglucose / Q000031:analogs & derivatives / Q000378:metabolism; D003925:Diabetic Angiopathies / Q000209:etiology*; D005632:Fructose / Q000378:metabolism; D005947:Glucose / Q000378:metabolism; D017127:Glycation End Products, Advanced / Q000378:metabolism; D006595:Hexosamines / Q000378:metabolism; D006801:Humans; D006943:Hyperglycemia / Q000150:complications*; D020928:Mitogen-Activated Protein Kinases / Q000502:physiology; D011108:Polymers / Q000378:metabolism; D019518:Postprandial Period; D011493:Protein Kinase C / Q000378:metabolism; D015398:Signal Transduction
D017127:Glycation End Products, Advanced; D006595:Hexosamines; D011108:Polymers; C024617:polyol; D005632:Fructose; D003847:Deoxyglucose; D011493:Protein Kinase C; D020928:Mitogen-Activated Protein Kinases; C016350:3-deoxyglucosone; D005947:Glucose